Is GW Pharmaceuticals developing products for the worldwide market?
GW’s strategy is to produce cannabis-based medicines for the worldwide market. Whilst GW will continue to regard its activities in the UK and Europe as its primary focus, it intends to develop further its activities in the United States. In addition, the Group will seek to roll out its products across the rest of the world.
